英科医疗控股股东部分股份解除质押，风险可控
【要点概述】
英科医疗科技股份有限公司（证券代码：300677，简称“英科医疗”）6月15日发布公告，披露公司控股股东刘方毅先生于近日完成了部分股份的质押解除手续。这一变动涉及370,000股，占刘方毅先生所持股份的0.16%，占公司总股本的0.06%。本次解除质押起始日为2025年8月7日，解除日期为2026年6月12日，质权人为国金证券资产管理有限公司。
一、股份质押及解除情况详解
- 本次解除质押股份数量：370,000股
- 占刘方毅所持股份比例：0.16%
- 占公司总股本比例：0.06%
- 质权人：国金证券资产管理有限公司
- 解除日期：2026年6月12日
- 公司最新总股本：654,753,263股
二、控股股东股份质押整体情况
- 刘方毅持股总量：231,703,107股，占公司总股本35.39%
- 累计质押股份：28,000,000股，占其持股12.08%，占公司总股本4.28%
- 所有已质押股份均为高管锁定股，无冻结、标记股份
- 未质押股份中，高管锁定股为145,777,330股，占未质押股份71.56%
三、对投资者的影响及风险提示
公告特别指出，控股股东刘方毅先生资信状况良好，具备良好的资金偿还能力。在本次部分股份解除质押后，其剩余质押股份不存在实质性资金偿还风险。目前所质押股份没有平仓风险或被强制过户的情形，整体质押风险可控，不会对公司生产经营、治理结构等产生影响。公司也承诺将持续关注其质押变动，并按规定及时披露相关信息。
四、投资者需关注事项
- 控股股东质押股份比例处于可控水平，短期内不存在平仓或强制过户风险。
- 本次解除质押股份数量较小，对公司整体股权结构影响有限。
- 公告如实披露了股份质押及解除详情，有助于提升公司治理透明度。
- 高管锁定股比例较高，有助于稳定公司股权结构。
五、结语
本次股份解除质押事项总体风险可控，不存在对公司经营和股价产生重大负面影响的情形。但投资者仍需持续关注公司后续质押及解押动态。
免责声明：本文内容仅作信息披露用途，不构成任何投资建议。投资者据此操作，风险自担。
Yingke Medical: Partial Release of Share Pledge by Controlling Shareholder, Risk Under Control
Key Highlights
Yingke Medical Technology Co., Ltd. (Stock Code: 300677, “Yingke Medical”) announced on June 15 that its controlling shareholder, Mr. Liu Fangyi, has recently completed the release of pledge on part of his shares. This involves 370,000 shares, accounting for 0.16% of Liu Fangyi’s holdings and 0.06% of the company’s total share capital. The pledge started on August 7, 2025 and was released on June 12, 2026. The pledgee was China Fortune Securities Asset Management Co., Ltd.
1. Details of Share Pledge and Release
- Number of shares released: 370,000 shares
- Proportion of Liu Fangyi’s holdings: 0.16%
- Proportion of total share capital: 0.06%
- Pledgee: China Fortune Securities Asset Management Co., Ltd.
- Release date: June 12, 2026
- Latest total share capital: 654,753,263 shares
2. Overall Status of Shareholder’s Pledged Shares
- Total shares held by Liu Fangyi: 231,703,107 shares, representing 35.39% of the company
- Cumulative pledged shares: 28,000,000 shares, 12.08% of his holdings, 4.28% of total share capital
- All pledged shares are executive lock-up shares, with no frozen or marked shares
- For unpledged shares, executive lock-up shares amount to 145,777,330 shares, 71.56% of unpledged shares
3. Impact on Investors and Risk Alert
The announcement emphasizes that Mr. Liu Fangyi has good credit standing and repayment ability. After this partial share pledge release, there remains no substantive repayment risk regarding his pledged shares. There is currently no risk of forced sale or transfer, and the overall pledge risk is under control, with no impact on the company’s operations or governance. The company promises to continue monitoring any changes and disclose information as required.
4. Key Takeaways for Investors
- The proportion of pledged shares by the controlling shareholder is at a controllable level, with no short-term risk of forced sales.
- The number of shares released is relatively small and has limited impact on the company’s overall equity structure.
- The announcement’s transparency regarding pledge details enhances corporate governance.
- The high proportion of executive lock-up shares helps maintain stability in the company’s equity structure.
5. Conclusion
The share pledge release has overall controllable risk and does not pose a significant negative impact on the company’s operations or share price. However, investors should continue to monitor the company’s pledge and release developments.
Disclaimer: The content above is for information disclosure only and does not constitute investment advice. Investors act at their own risk.
